Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.

Ashford S, Turner-Stokes L.

Physiother Res Int. 2013 Sep;18(3):178-89. doi: 10.1002/pri.1554. Epub 2013 Apr 30. Review.

PMID:
23630050
2.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

3.

Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.

Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD009689. doi: 10.1002/14651858.CD009689.pub2. Review.

PMID:
23740539
4.

Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.

Shaw LC, Price CI, van Wijck FM, Shackley P, Steen N, Barnes MP, Ford GA, Graham LA, Rodgers H; BoTULS Investigators.

Stroke. 2011 May;42(5):1371-9. doi: 10.1161/STROKEAHA.110.582197. Epub 2011 Mar 17.

5.

Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.

Bensmail D, Robertson JV, Fermanian C, Roby-Brami A.

Neurorehabil Neural Repair. 2010 Mar-Apr;24(3):273-81. doi: 10.1177/1545968309347682. Epub 2010 Jan 12.

PMID:
20067949
6.

Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function.

Ashford S, Jackson D, Turner-Stokes L.

Physiotherapy. 2015 Mar;101(1):88-94. doi: 10.1016/j.physio.2014.04.001. Epub 2014 Apr 18.

PMID:
24954806
7.

Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.

Elia AE, Filippini G, Calandrella D, Albanese A.

Mov Disord. 2009 Apr 30;24(6):801-12. doi: 10.1002/mds.22452. Review.

PMID:
19224614
8.

Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.

Ashford S, Slade M, Turner-Stokes L.

Disabil Rehabil. 2013 Aug;35(18):1513-8. doi: 10.3109/09638288.2012.743602. Epub 2013 Jan 7.

9.

Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.

Ashford S, Turner-Stokes L, Siegert R, Slade M.

Clin Rehabil. 2013 Aug;27(8):728-40. doi: 10.1177/0269215512474942. Epub 2013 Feb 20.

PMID:
23426566
10.

Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.

Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.

J Rehabil Med. 2010 Jan;42(1):81-9. doi: 10.2340/16501977-0474.

11.
12.

Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.

Bell KR, Williams F.

Phys Med Rehabil Clin N Am. 2003 Nov;14(4):821-35. Review.

PMID:
14580040
13.

Use of botulinum toxin in stroke patients with severe upper limb spasticity.

Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA.

J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):30-5.

14.

Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?

Nott MT, Barden HL, Baguley IJ.

J Rehabil Med. 2014 Oct;46(9):864-8. doi: 10.2340/16501977-1853.

15.

Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.

Teasell R, Foley N, Pereira S, Sequeira K, Miller T.

Top Stroke Rehabil. 2012 Mar-Apr;19(2):115-21. doi: 10.1310/tsr1902-115. Review.

PMID:
22436359
16.

Botulinum toxin in poststroke spasticity.

Ozcakir S, Sivrioglu K.

Clin Med Res. 2007 Jun;5(2):132-8. Review.

17.

Evaluation of functional outcome measures for the hemiparetic upper limb: a systematic review.

Ashford S, Slade M, Malaprade F, Turner-Stokes L.

J Rehabil Med. 2008 Nov;40(10):787-95. doi: 10.2340/16501977-0276. Review.

18.

Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.

Gracies JM, Bayle N, Goldberg S, Simpson DM.

Arch Phys Med Rehabil. 2014 Jul;95(7):1303-11. doi: 10.1016/j.apmr.2014.03.016. Epub 2014 Apr 4.

PMID:
24709034
19.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.

PMID:
19142573
20.

Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.

McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.

J Rehabil Med. 2009 Jun;41(7):536-44. doi: 10.2340/16501977-0366.

Supplemental Content

Support Center